Kabimustine 100 mg Injection 1's contains Bendamustine, which belongs to the class of alkylating agents. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells. This medicine is used in the treatment of chronic lymphocytic leukemia and non-Hodgkin’s leukemia.

FAQs

How does Kabimustine 100 mg Injection 1's work?

Kabimustine 100 mg Injection 1's contains Bendamustine, which inhibits the DNA and RNA transcription essential for cancer cell growth.

What are the conditions to be noted while receiving Kabimustine 100 mg Injection 1's?

Kabimustine 100 mg Injection 1's may cause reactivation of serious infections, myelosuppression, tumour lysis syndrome, and anaphylactic reactions in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.